Phase 3 data reported a skin-sensitivity side effect called dysesthesia, described as tingling or tenderness to touch, in about 20.9% of participants at the highest dose
It is continuously researched for a number of therapeutic applications in relation to its healing potential, which could be used to overcome soft and hard tissue injuries, GI disorders, and inflammatory diseases, just to name a few conditions [2, 3, 4, 5, 6]
Item etal, 2004), and reduced production of CoQ10, both of which would lead to poor muscle tone
BPC-157 Protocols: The Essential Handbook for Regeneration and Health: BPC157 Peptides
A 2016 study noted its impact on reducing gut inflammation and protecting against ulcers
The dosage is based on medical condition, response to the treatment, age, and weight